A Phase Ib Study ofSingle-AgentIdelalisib Followed by Idelalisib in Combination with Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma Article (Web of Science) Early Access (Web of Science)
Industry Collaboration